Literature DB >> 9493371

Production of a non-toxic site-directed mutant of Clostridium perfringens epsilon-toxin which induces protective immunity in mice.

P C Oyston1, D W Payne, H L Havard, E D Williamson, R W Titball.   

Abstract

A panel of ten site-directed mutants of Clostridium perfringens epsilon-toxin was generated. All of the mutated proteins expressed in Escherichia coli were recognized in immunoblots by a neutralizing mAb raised against wild-type native epsilon-toxin. The cytotoxicity of the site-directed mutated toxins was assayed in vitro against MDCK cells. One mutation resulting in loss of activity in the assay was identified. This non-toxic protein was derived by substituting a proline for the histidine at residue 106 of the toxin. Immunization of mice with the non-toxic mutated epsilon-toxin resulted in the induction of a specific antibody response and immunized mice were protected against 1000 LD50 doses of wild-type recombinant epsilon-toxin.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9493371     DOI: 10.1099/00221287-144-2-333

Source DB:  PubMed          Journal:  Microbiology (Reading)        ISSN: 1350-0872            Impact factor:   2.777


  20 in total

1.  Identification of tyrosine 71 as a critical residue for the cytotoxic activity of Clostridium perfringens epsilon toxin towards MDCK cells.

Authors:  Zhigang Jiang; Jitao Chang; Fang Wang; Li Yu
Journal:  J Microbiol       Date:  2015-01-28       Impact factor: 3.422

2.  F199E substitution reduced toxicity of Clostridium perfringens epsilon toxin by depriving the receptor binding capability.

Authors:  Jingjing Kang; Jie Gao; Wenwu Yao; Lin Kang; Shan Gao; Hao Yang; Bin Ji; Ping Li; Jing Liu; Jiahao Yao; Wenwen Xin; Baohua Zhao; Jinglin Wang
Journal:  Hum Vaccin Immunother       Date:  2017-03-17       Impact factor: 3.452

3.  Correlation between plasmid content and infectivity in Borrelia burgdorferi.

Authors:  J E Purser; S J Norris
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

4.  A low-toxic site-directed mutant of Clostridium perfringens ε-toxin as a potential candidate vaccine against enterotoxemia.

Authors:  Qing Li; Wenwen Xin; Shan Gao; Lin Kang; Jinglin Wang
Journal:  Hum Vaccin Immunother       Date:  2013-07-08       Impact factor: 3.452

5.  Identification of amino acids important for binding of Clostridium perfringens epsilon toxin to host cells and to HAVCR1.

Authors:  Susan E Ivie; Mark S McClain
Journal:  Biochemistry       Date:  2012-09-12       Impact factor: 3.162

6.  Functional analysis of neutralizing antibodies against Clostridium perfringens epsilon-toxin.

Authors:  Mark S McClain; Timothy L Cover
Journal:  Infect Immun       Date:  2007-01-29       Impact factor: 3.441

7.  Dominant-negative inhibitors of the Clostridium perfringens epsilon-toxin.

Authors:  Teal M Pelish; Mark S McClain
Journal:  J Biol Chem       Date:  2009-08-31       Impact factor: 5.157

8.  Gene-trap mutagenesis identifies mammalian genes contributing to intoxication by Clostridium perfringens ε-toxin.

Authors:  Susan E Ivie; Christine M Fennessey; Jinsong Sheng; Donald H Rubin; Mark S McClain
Journal:  PLoS One       Date:  2011-03-11       Impact factor: 3.240

9.  New Mutants of Epsilon Toxin from Clostridium perfringens with an Altered Receptor-Binding Site and Cell-Type Specificity.

Authors:  Jonatan Dorca-Arévalo; Inmaculada Gómez de Aranda; Juan Blasi
Journal:  Toxins (Basel)       Date:  2022-04-16       Impact factor: 5.075

10.  Clostridium perfringens epsilon toxin H149A mutant as a platform for receptor binding studies.

Authors:  Monika Bokori-Brown; Maria C Kokkinidou; Christos G Savva; Sérgio Fernandes da Costa; Claire E Naylor; Ambrose R Cole; David S Moss; Ajit K Basak; Richard W Titball
Journal:  Protein Sci       Date:  2013-04-08       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.